Condensed Consolidated Balance Sheets (USD $)	Jan. 31, 2014	Oct. 31, 2013
Current assets:
Cash		$ 5,007
Inventories	67,487	67,487
Prepaid expenses	2,928	897
Total current assets	70,415	73,391
Fixed assets, net	97,186	111,570
Total assets	167,601	184,961
Current liabilities:
Bank overdraft	5,983
Notes payable to stockholder, net of unamortized discount of $0 and $844 in 2014 and 2013, respectively	235,450	200,606
Convertible notes payable, net of unamortized discount of $57,394 and $60,050 in 2014 and 2013, respectively	109,973	89,818
Accounts payable - trade	357,259	336,372
Accounts payable to officers and directors	155,989	131,472
Accrued payroll	312,681	244,031
Derivative liability	87,136	75,557
Anti-dilution liability	20,087	23,358
Other accrued expenses	87,590	81,016
Total current liabilities	1,372,148	1,182,230
Long term liabilities:
Redeemable convertible preferred stock, $0.01 par value; 5,200 shares authorized, issued and outstanding at January 31, 2014 and October 31, 2013, respectively	26,000	26,000
Total long term liabilities	26,000	26,000
Total liabilities	1,398,148	1,208,230
Commitments and contingencies
Stockholders' (deficit):
Common stock, $0.01 par value; 25,000,000 shares authorized; 5,381,333 and 5,153,027 shares issued and outstanding at January 31, 2014 and October 31, 2013, respectively	53,814	51,531
Additional paid-in capital	45,699,303	45,335,031
Accumulated deficit from previous operating activities	(27,809,201)	(27,809,201)
Deficit accumulated during the development stage	(19,174,463)	(18,600,630)
Total stockholders' (deficit)	(1,230,547)	(1,023,269)
Total liabilities and stockholders' (deficit)	$ 167,601	$ 184,961